Share

Erik Olsson new Investment Manager at Curus

20 Sep - 2022

Curus strengthens the team and continues its focus on investments in digital health by recruiting Erik Olsson as new Investment Manager.
Erik joins Curus from SEB Corporate Finance where he worked with M&A and ECM transactions in the Nordics.
Johan Bloom, CEO of Curus, comments: “I am very proud that we have succeeded in recruiting Erik to Curus.
Erik complements me well with both solid transaction experience from M&A and capital raising for large and medium-sized companies in the Nordic region.
With Erik’s experience from corporate finance and my experience and network in e-health, we have a very good team to accelerate investments and acquisitions to build companies in this fast-growing industry.
I am excited to start working with Erik and continue building on Curus’ vision.
Recently, Alfvén & Didrikson, Stefan Bengtsson and Alex Stendahl invested SEK 136 million in Curus to take a dominant position in digital health in the Nordic region.
Today, Curus has 22 holdings in growth companies such as Mindler, Doctrin, Colivia, FindOut Diagnostic, Knodd, Health Integrator and others, as well as two wholly owned subsidiaries in Add Health Media and the newly acquired Pharma Industry Publishing.
– I am very happy to join Curus and start the work of accelerating Curus’ investments in digital health.
It’s exciting to change sides of the table while having the opportunity to continue supporting companies and entrepreneurs in their growth ambitions.
We are facing an exciting time with external factors that mean that there are great opportunities to grow Curus through new acquisitions and at the same time support our portfolio companies in a fast-moving digital landscape in healthcare and health, says Erik Olsson, Investment Manager at Curus.
Erik holds a Master of Science in Economics from Lund University, and in addition to SEB Corporate Finance, he has experience from Swedbank Corporate Finance and HDR Partners.  For more information: Johan Bloom, CEO Curus [email protected],+46 733 64 84 90 Erik Olsson, Investment Manager [email protected],+46 708 37 73 54  

More news

7 Nov - 2023

Successful health initiative in Region Stockholm exceeds target – more than 50% out of type 2 diabetes risk zone

20 Sep - 2023

Curus invests in Wellon

4 Sep - 2023

Curus Invests in Measurlabs, a Finnish Laboratory Analysis Platform

This website uses cookies to ensure you get the best experience on our website.